Singer Capital Markets appointed as Joint Broker to Venture Life Group plc
Singer Capital Markets is delighted to announce our appointment as Joint Broker to Venture Life Group plc with immediate effect.
The firm’s appointment to Venture Life Group means Singer Capital Markets has now partnered with 15 clients in 2020 – more than any other Broker in the small and mid-cap UK market.
About Venture Life Group plc
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands, these are supplied direct by the company to retailers, elsewhere they are supplied by the Group’s international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies for consumer healthcare products, primarily medical devices.
Market Cap: £66.55 million*
Website: Click here
* As at 13/07/2020